Year-on-year gain: 700 percent
Market cap: AU$220.22 million
Share price: AU$1.92
The first top-gaining ASX tech stock on this list is SKS Technologies, which designs and installs advanced electrical technology solutions, including converged audio-visual/information technology, electrical and communication networking systems across Australia.
That same month, SKS confirmed a AU$13.5 million contract for the supply and installation of electrical systems for an international hyperscale data centre in Melbourne through Built, one of Australia’s largest construction firms. SKS was awarded another AU$20 million contract through Built in September, along with a AU$22 million data centre contract with Erilyan Projects, a major construction company.
For its fiscal year 2024 ending June 30, SKS reported sales revenues of AU$136.31 million, up 63.7 percent from the previous year. For its fiscal year 2025 guidance, the company is looking towards a forecasted AU$200 million in sales revenue.
Year-on-year gain: 350 percent
Market cap: AU$25.91 million
Share price: AU$0.081
Year-on-year gain: 350 percent
Market cap: AU$32.54 million
Share price: AU$0.135
Next on this list of top-gaining ASX tech stocks is NoviqTech, an AI and distributed ledger technology company that provides clients in various sectors of industry with supply chain, carbon emissions and guarantee of origin reporting services.
Year-on-year gain: 326.83 percent
Market cap: AU$43.65 million
Share price: AU$0.175
Singular Health Group is a medical imaging technology company. Its technology platform incorporates 3D printing, virtual reality and AI for helping medical professionals and patients plan for surgery. The company’s 3Dicom software solutions is cleared for diagnostic use in the United States and is used in medical education.
In November, Singular signed a memorandum of understanding with Florida, US, based managed service organisation Provider Network Solutions (PNS) for Singular Health’s 3Dicom software. PNS, which has more than 3.7 million member plans under management, also agreed to a AU$500,000 equity investment in Singular Health.
Year-on-year gain: 324.79 percent
Market cap: AU$602.3 million
Share price: AU$2.57
Appen operates as a trusted partner to firms transitioning to AI usage, with a suite of industry-specific large language models and AI-training products.
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Leave a Reply